# Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis

> **NCT04077736** · PHASE2 · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 10 (actual)

## Conditions studied

- Relapsing Polychondritis

## Interventions

- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT04077736
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-01
- **Primary completion:** 2023-10-10
- **Final completion:** 2023-10-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04077736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04077736, "Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04077736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*